National Health Investors (NYSE:NHI) Updates FY 2024 Earnings Guidance

National Health Investors (NYSE:NHI) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 4.430-4.440 for the period, compared to the consensus earnings per share estimate of 4.500. The company issued revenue guidance of -. National Health Investors also updated its FY24 guidance to $4.43-$4.44 EPS.

National Health Investors Trading Up 1.1 %

Shares of NYSE:NHI traded up $0.81 during mid-day trading on Tuesday, reaching $76.73. The stock had a trading volume of 340,585 shares, compared to its average volume of 190,436. The firm has a market cap of $3.33 billion, a PE ratio of 26.00, a price-to-earnings-growth ratio of 5.09 and a beta of 1.05. The firm has a 50 day simple moving average of $80.53 and a two-hundred day simple moving average of $73.03. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. National Health Investors has a twelve month low of $49.25 and a twelve month high of $86.13.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.10 by ($0.29). The firm had revenue of $84.97 million during the quarter, compared to analyst estimates of $64.95 million. National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. National Health Investors’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period last year, the firm earned $1.06 EPS. On average, research analysts predict that National Health Investors will post 4.48 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have issued reports on NHI. Truist Financial increased their price target on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and upped their price target for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Bank of America started coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective on the stock. Finally, StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Four analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.